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Abstract: 
 
HIV-1, an enveloped RNA virus, produces viral particles that are known to be much more 
heterogeneous in size than is typical of non-enveloped viruses. We present here a novel 
strategy to study HIV-1 Viral Like Particles (VLP) assembly by measuring the size 
distribution of these purified VLPs and subsequent viral cores thanks to Atomic Force 
Microscopy imaging and statistical analysis. This strategy allowed us to identify whether the 
presence of viral RNA acts as a modulator for VLPs and cores size heterogeneity in a large 
population of particles. These results are analyzed in the light of a recently proposed 
statistical physics model for the self-assembly process. In particular, our results reveal that the 
modulation of size distribution by the presence of viral RNA is qualitatively reproduced, 
suggesting therefore an entropic origin for the modulation of RNA uptake by the nascent 
VLP.   
 
Introduction 
 
Viral life cycle has been investigated for several decades, and significant progresses in the 
understanding of its different steps at the molecular level have been achieved[1,2]. Different 
viruses from different families show in particular distinct self-assembly pathways. In the case 
of non-enveloped viruses, the protein self-assembly is performed in the cytosol of the host 
cell. In vitro reconstitution by mixing recombinant capsid proteins with or without their 
nucleic acid under various environmental conditions allows one to show that capsid sizes and 
morphologies are not unique[2,3]. However, the self-assembly conditions met in the host cell 
select a particular capsid morphology, and give rise to relatively small polymorphism and size 
heterogeneity in vivo[4].  
In contrast to this observation, retroviruses exhibit quite a large polymorphism and 
size polydispersity in vivo for similar growth conditions[5]. The particular complex assembly 
pathway for retroviruses is likely to be responsible for such a polydispersity, although this has 
never been firmly established. The HIV-1 assembly scenario is composed of at least three 
consecutive steps: the multimerization of the viral Gag proteins at the plasma membrane, the 
budding of the viral particle and its subsequent maturation. During the budding step, the viral 
Gag proteins, which are the major constituent of the viral particle, self-assemble at the plasma 
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membrane in a cooperative way with the viral dimeric RNA[6]. Interestingly, some cellular 
RNA’s of the host cell have been shown to be incorporated as well within the nascent 
particle[7,8]. As with other RNA viruses, the HIV-1 genomic RNA bears a specific Packaging 
Signal (PSI or “ψ”) enhancing its preferential uptake into VLPs[9,10]. The assembly site will 
buckle out of the bilayer host cell membrane as more proteins are incorporated, leading to an 
almost spherical particle connected to the bulk membrane through a thin neck[11]. The 
recruitment of additional protein complexes from the ESCRT family allows the liberation of 
the particle[12]. During the maturation step, the HIV-1 Gag protein is processed by the viral 
protease into its component domains MA, CA and NC, and the linker peptides sp1, sp2 and 
p6, resulting in significant structural changes of the virion[13] . 
Both the budding and maturation steps have been studied independently with various 
assays[13,14]. These in vitro studies using specific or non specific nucleic acids have 
provided important clues about the retroviral assembly pathways. However, the global 
understanding is far from being complete. In particular there are at least two unanswered 
questions about self-assembly mechanism: (i) what is the origin of the large size 
polydispersity observed for viral particles produced by infected cells, and (ii) what are the 
molecular factors that control this phenomenon?  In order to address these questions, the 
morphological properties of purified virus-like particles (VLP) and mature viral cores 
produced by cells were investigated.   
In the present work, we propose and illustrate a novel strategy in order to make 
progress in the identification of the main determinants of virion morphology and size 
variability. The idea is to be able to quantify precisely the size distribution of viral particles 
produced by cells, and to use this size heterogeneity as a global reporter for HIV-1 assembly 
within cells. We applied this strategy by using a unique combination of retrovirus purification 
protocols, biochemical tools, Atomic Force Microscopy (AFM) imaging at the single virus 
level and automated image analysis. AFM was used in this study for its capacity to image a 
large number of individual particles: the adsorption of the molecular objects on a surface prior 
to AFM imaging increases significantly the number of objects effectively probed. Moreover 
the automated analysis of topographic images is facilitated as compared to other technique 
like cryo-EM[15] . AFM also allows to probe the mechanical properties of the particles, as it 
was recently done on HIV-1 derived particles by Kol and coworkers[16]
,
[17]. Using AFM in 
order to image viruses, we analyzed the statistical properties of large populations of HIV-1 
derived virus-like particles (VLP) and cores in the presence or in the absence of viral RNA. 
Using this approach, we showed that the presence of viral RNA is one of the determinants of 
the VLP size polydispersity: particles that contain viral RNA are smaller on average and more 
homogeneous in size in comparison with particles that packaged other cellular RNAs in place 
of the viral genome. These observations are interpreted using a general modeling of the viral 
particle self-assembly process. The model is based on the classical description used to address 
quantitatively the thermodynamical properties of micellization[18]. Within this approach, it is 
found that the RNA control of HIV-1 size polydispersity observed in the experiments is 
qualitatively reproduced. This strongly suggests that the observed control of particle size is 
associated to entropic effects during the self-assembly. 
 
Results 
Biochemical characterization 
The first step prior to size characterization was to produce and purify virus-like particles 
(VLP) and viral cores according to the procedure described in the Material and Method 
section. In order to check whether the combined steps of particle production and purification 
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led to biologically relevant VLPs and cores, we first analyzed their protein content by 
performing immunoblot analysis (Fig.1a). 
 For mature VLPs, pr55 Gag cleavage products (CAp24, MAp17) were mainly detected by 
immunoblots with anti-MA and anti-CA antibodies (Fig. 1a, lane 1 “VLP”). The viral 
enzymes integrase (IN) and reverse transcriptase (RT) were also found in mature VLPs as 
shown by immunoblots with the corresponding antibodies (Fig. 1a, lane 1“VLP”, IN and RT). 
In contrast, in purified cores, while the CA proteins were present, the MA protein as part of 
the viral membrane disappeared in the isolated cores and no immature p55Gag was detected 
(Fig. 1a, lane 2 ”cores”) as expected since MA remains attached to the viral membrane. RT 
and IN were also found in the mature cores. The two subunits of RT (p66 and p51) and 
Integrase were detected in mature VLPs and cores, with a lower intensity for cores, indicating 
that during triton purification of cores from VLPs some instable cores or particles get lost.  
Immunoblots of VLPs and cores prepared without viral ψRNA were similar to those shown in 
figure 1 a. In addition, to further check that VLP and cores were functional after purification, 
their reverse transcriptase activities were estimated (Fig.1b). As expected, RT activity was 
detected in both VLP and cores (+ or – viral ψRNA), with about half or one third less efficacy 
for the purified mature cores, in agreement with immunoblot analysis.   
 
 
AFM imaging and particle characterization 
The purified samples were then deposited on poly-L-lysine-coated mica surfaces and dried for 
air-imaging with Atomic Force Microscope (see Material and Methods). Simple visual 
analysis of VLPs and cores by AFM images confirms the presence of objects with appropriate 
sizes and morphological features. This simple consistency check was performed for each 
purification. Examples of typical mature VLP and core images are shown respectively in 
figure 1c and 1d. One can recognize spherical shape VLP of about 100nm in average diameter 
(Fig 1c) and typical HIV conical shape cores (Fig 1d) with an average length of 75nm and 
width of 50nm. In order to be able to sort in an objective way different populations within one 
single purification condition based on morphological features, we developed home-made 
automated image analysis scripts (see Material and Methods). These tools enable the sorting 
of objects according to the simultaneous consideration of their height and lateral size (Figure 
2).  VLPs are automatically detected on images by focusing on particles that have both a 
minimal height (typically 25nm) and a minimal lateral size (typically 90nm in diameter). In 
the case of purification containing cores, these thresholds have been adapted in order to focus 
on this population. 
 
The statistical comparison of size and shape parameters for VLP and cores is shown in figure 
3. The clear difference in asymmetry of VLP and cores observed on the selected particles of 
figure 1b and 1c is quantified at a statistical level using 2D histograms of long diameter as 
function of short diameter for each particle (see also Figure S3 in supplementary material). It 
is observed that the size distribution of VLP has a large dispersion, and that this dispersion is 
isotropic, i.e. the distribution is smeared along the line for which the short and the long 
diameter are equal. The dispersion (between 10 and 20 nm) is relevant to the self-assembly 
process, since it is larger than the resolution associated to the convolution of samples with tip 
size (roughly 5 nm). The comparison of this large dispersion with dispersion measured for 
other non-enveloped RNA viruses (typically between 5 and 10 nm) indicates indirectly that 
size control during the self-assembly process is not as stringent for HIV-1[4,19]. On the other 
hand, the dispersion of particles from core purification is smaller and it is essentially observed 
on the long axis of the particles. Indeed, the large dispersion observed for VLP is partially 
transmitted to the long axis of the conical capsid (between 10 and 20 nm). The dispersion 
! 4!
along the minor axis is strongly reduced, reflecting a more stringent control of this particular 
dimension of the conical capsid (between 5 and 10 nm). Our measurements are in quantitative 
agreement with previous cryo-EM characterization by Briggs et al[20]. 
 
The presence of viral RNA modulates VLP size polydispersity 
Having established the size distribution of HIV-1 VLPs, we compare these distributions for 
particles differing in viral RNA content. These particles are produced by two distinct 
methods: in the first method, VLP are produced using a single transfection of a plasmid 
encoding Gag/Gag Pol proteins in a lentiviral vector[21]. In the second method, the particles 
are produced by adding in the same transfection step another plasmid expressing a non 
infectious HIV-1 ψRNA[22]. As a consequence, the second type of particles contains mainly 
viral ψRNA (" VLP +ψ ") , while the first type mainly contain cellular RNAs in place of the 
viral RNA (" VLP -ψ "), as it has been previously described [7,8]. Interestingly, it has been 
previously shown that VLP +ψ particles do contain also a significant amount of cellular 
RNAs. We first checked that the size distribution of VLP +ψ is not significantly dependent on 
the amount of plasmid expressing viral RNA used for the transfection (Figure S4 in the in 
supplementary material.). Next, the comparison of the size distribution for the two types of 
particles  +ψ and -ψ are shown in figure 4. In the case of VLP, both the peak position of the 
2D size distribution (long diameter/short diameter) and its dispersion are changed: VLP +ψ 
particles are smaller on average and less polydisperse (average diameter= 98nm and standard 
deviation=7nm) than VLP -ψ particles (average diameter= 106nm and standard 
deviation=11nm). A shift in the 2D size distribution is also observed for cores purified from 
the two previous types of particles, although with a lower amplitude. These results are 
summarized in figure 4e by using a box plot representation. Both in the case of  VLP and 
cores, a statistical test confirm that the size distributions from  -ψ and +ψ are different (p-
values=2.10
-7
 for VLP and 7.10
-10
 for cores) (Fig.4e). In addition, since we did not find 
significant differences between size distributions of +ψ for different plasmid expression in our 
experimental conditions (figure S4 in supplementary material), this suggests that the change 
in particle size distribution is rather an all-or-none effect requiring only a small amount of 
viral +ψ plasmid expression. Overall, our results suggest that from a statistical point of view 
the presence of a viral RNA allows the significant modulation of HIV-1 particle size 
variability. Interestingly, we also checked that AFM imaging in liquid environment, although 
much difficult to achieve, gives essentially the same results about the role of viral RNA on 
VLP morphology. Indeed, the relative effect of size average and polydispersity of VLP 
population upon the presence of viral RNA is consistent. These results are available in the 
supplemental material (figure S5 in supplementary material). 
 
Thermodynamics of viral assembly in the presence of viral and cellular RNAs 
It is possible to understand with very general physical arguments how RNA might influence 
the size distribution of viral particles. More precisely, we present below a simple statistical 
model of virus self-assembly that is able to reproduce the main observation of our study: the 
presence of viral RNA is significantly favoring smaller size particles. The derivation of the 
model is postponed to the supplemental data, and qualitative physical arguments summarizing 
the results of the model are proposed below. Moreover, the reader is referred to a recently  
published thorough analysis of the self-assembly equations for more details[23]. 
 
First, it must be realized that the process of viral proteins self-assembly (in the absence of 
viral RNA) in order to form capsids is controlled by the balance between enthalpic and 
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entropic effects: on the one hand the enthalpy represents the free energy gained by individual 
proteins at forming each capsid, and on the other hand the entropy represents the number of 
ways to assemble these capsids at constant internal energy[18,19,24] . At this step, an 
interesting observation can be made : if the enthalpy is only weakly selective in capsid size, 
the entropy will favor smaller particles, because more « small » particles can be made than 
« large » particles at constant number of total proteins, leading to larger entropy for the 
former and smaller entropy for the latter. Now we claim that the uptake of RNA inside viral 
particles allows to modulating the population ratio of these particles thanks to similar entropic 
effects. More precisely, the consequence of the presence of multiple types of RNA during the 
self-assembly of capsids is two fold: first, entropy will favor the uptake of longer RNAs like 
viral genomes, and second, their capsid preferred size is shifted to smaller values. These 
behaviors are illustrated below. 
 
As we already mentioned it, the two types of particles of interest in our study are VLP 
+ψ particles, which are thought to contains mainly viral RNA, and also some cellular RNAs, 
and VLP -ψ which are thought to contain mainly cellular RNAs[8] . In the study by Rulli and 
co-workers, the amount of RNAs in each particle has been quantified, and it turns out that the 
total amount of RNA is roughly the same in these two types of particles. Such a linear relation 
between the total nucleotides of RNA and the number of proteins in the capsid is generally 
observed for RNA viruses[18,25]. Recent works suggest that this feature is based on the 
electrostatic interactions between proteins in the capsid and RNA. As a consequence, in VLP 
-ψ particles, some cellular RNAs present in the cytoplasm replace the viral RNA in order to 
maintain a constant level of RNA in each particle. Since viral RNA is known to have a larger 
nucleotide length than most of cellular RNAs this has a strong impact on the number of ways 
capsid can be assembled in their presence, or equivalently on the total configuration entropy 
for capsid formation. Indeed, the replacement of several « small » cellular RNAs by the two 
« large » dimerized viral RNAs allows the formation of a larger number of VLP +ψ  particles 
at constant amount of cellular RNAs, as the effective number of cellular RNAs is reduced in 
VLP +ψ  particles. As a consequence, VLPs containing large viral RNA are intrinsically more 
favorable in terms of the entropic cost for the self-assembly than VLPs containing only 
cellular RNAs.  
 
 This is illustrated by numerical calculations based on the simple micellization 
thermodynamic model which has been used in order to describe the aggregation properties of 
surfactant solutions and which is presented in the Material and methods section. The key idea 
of the calculation is to restrict the product of the self-assembly to two final states: two 
particles of the same size, but of different RNA content (Figure 5a). The restriction to two 
final states allows to determine whether particles containing both viral and cellular RNAs are 
favored as compared to particles containing only cellular RNAs, as input parameters or 
environmental conditions are modulated. This choice of a bimodal model is consistent with 
results of more complex calculations including polydispersity effects[23] . The titration curve 
of figure 5b shows that the concentration of particles containing large viral RNA is dominant 
as the concentration of large RNA is increased, illustrating the entropic selection mechanism 
mentioned above. Interestingly, it was found by Rulli and co-workers that some cellular 
RNAs detected in VLPs, in replacement of viral RNA, have indeed large length (about 7000 
nt)[8]. This observation fits nicely the proposed mechanism of entropic RNA selection: 
incorporation of larger RNAs, such as messenger RNA, allows VLP assembly and the 
production of a larger amount of particles at constant cellular RNA amounts. In this case, the 
entropic selection mechanism will therefore strengthen the effect of the specific packaging 
signal ψ, that has been shown to be the main driving force of specific RNA uptake[8].  
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 Similar calculations can be performed in the case where the two final states represent 
two particles with both different sizes and different RNA content. Specializing the previous 
model to small particles containing large viral RNA and cellular RNAs, and large particle 
containing mainly cellular RNAs, one finds again that small particles will dominate over large 
particles once a critical large RNA concentration has been reached (Figure 6). This behavior 
is qualitatively understood as follows. Considering first the case without RNA, if the enthalpy 
of formation of each capsid is only weakly selective in terms of capsid size, smaller capsids 
will be preferred for entropic reasons because they can be more numerous at fixed amount of 
proteins. The combination of this effect to the previous one of entropic selection of large 
genome leads to the prediction that small particles incorporating large RNA will be the 
dominant product of capsid self-assembly, and that the sizes of capsids are shifted to smaller 
values. This is nicely illustrated by comparing in figure 6b the shift of the boundary 
separating large RNA/no large RNA populations towards smaller large RNA volume fraction. 
Discussion 
 
Using Atomic Force Microscopy in order to image purified HIV-1 VLP produced by 
transfected human cells, we were able to quantify size distributions of VLP. The relevance of 
these size distributions was checked by performing the following control experiments. Indeed, 
the current purification scheme based on sucrose gradient is efficient in order to collect VLPs, 
but it has the side-effect of letting through small cellular vesicles of similar density called 
”exosomes”[26]. These are natural secretion products of cells under the present growth 
conditions. We quantified the size distribution of these additional cellular particles using 
transfection assays with a "mock" plasmid that is not coding for Gag or other viral proteins 
(“mock” conditions).  Since the majority of these cell particles have sizes smaller than 90nm 
(Figure S1 in the supplemental material) and since VLP are not expected in this range, it is 
possible to get rid of the statistical contribution of exosomes within VLP purification 
conditions by imposing a lower size threshold of 90nm, as it is shown in figure S1 in 
supplementary material. Thus we are confident that in our study we mainly consider from a 
statistical point of view HIV-1 VLP and not exosomes. Moreover, the observed effect of RNA 
control of HIV-1 size polydispersity discussed below survives if exosome particles are kept in 
the analysis (cf Figure S2 in supplementary material). 
We were also able to quantify the size distribution of VLP in the presence or in the absence of 
viral ψ-RNA. Our results show that these distributions are significantly different from a 
statistical point of view. Since the particles are produced in the same cell batch, the observed 
difference in size distribution is likely due to the direct influence of the viral RNA presence or 
absence, on the global self-assembly pathway. Up to our knowledge, this is the first time such 
an effect has been quantified on HIV-1 particles. This constitutes the main message of our 
work. Interestingly, a similar modulation of particle size and morphology has been recently 
evidenced within in vitro self-assembly on a plant RNA virus, the Cowpea Chloritic Mottle 
Virus (CCMV), by mixing purified capsid proteins with RNAs of controlled length[4,27] . In 
these works, it is shown that viral particles of CCMV are able to incorporate multiple copies 
of exogenous RNA which are smaller than the wild-type genome. Moreover, these particles 
are more heterogeneous in size than wild-type viral particles. This shows directly that the 
RNA content for this virus is able to modulate the size distribution of viral particles, similarly 
to our own observations with HIV-1. Additionally, recent observations on members of the 
paramyxoviruses family, such as the Newcastle Disease Virus also claim directly for a 
modulation of viral particle size by the stoichiometry of viral genome [28]. Indeed, it was 
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observed in this case that a majority of infectious VLPs are small and contain a single 
genome, while a minority are large and contain multiple genomes. 
 
 
In the case of HIV-1, the situation is necessarily more complex, due to the inherent greater 
complexity of the self-assembly scenario and to the lack of experimental control of molecular 
ingredients within cells during viral assembly, as compared to the framework of controlled  in 
vitro self-assembly experiments by Cadena-Nava and co-workers[4] . However, it has been 
shown that RNA plays a role in retroviral assembly[7,29,30]. Moreover, retroviruses 
incorporate viral RNA as well as cellular RNA of different sizes and categories (mRNA, 
tRNA and 7S RNA for example). In the absence of viral genomic RNA, retroviruses 
compensate the lack mainly by incorporating cellular mRNA[7,8]. But none of these studies 
have shown a difference of morphogenesis in retroviral assembly of VLP with or without 
viral RNA. Our work suggests that the difference lies essentially in the size distribution of 
VLP, which is significantly smaller in the presence of viral RNA, and more homogeneous.  
Using simple argument of micellization thermodynamics, we were able to reproduce 
qualitatively the previous observations of size modulation by the presence of viral RNAs. In 
particular, for viral particles with equal sizes but different RNA content, there is an entropic 
selection of large viral RNA. Moreover, for viral particles with both unequal sizes and 
different RNA content, there is an entropic selection of both small particle size and large viral 
RNA. In order to obtain these results, a number of simplifying assumptions have been 
obviously made, and therefore are likely to prohibit a quantitative comparison between the 
model and the data. One of the strongest assumption is that the energetic cost of particle 
formation is only loosely size selective, allowing therefore entropic effects to dominate in the 
model. In the case of HIV-1, this assumption is realistic, since we measured that VLPs have 
indeed a large size dispersion. The reason for such a large dispersion is not known, but it 
might be related to the recently observed incompleteness of the protein layer underlying the 
membrane envelope: indeed the weak size dispersion of non-enveloped viruses has been 
recently linked to the bending cost of the complete and ordered protein layer within the 
capsid, while for incomplete protein layers of non-envelope this cost should be strongly 
reduced and therefore the control of size dispersion through bending cost should not be 
efficient[19]. Interestingly, self-assembly of Gag proteins on monodisperse gold particles 
covered by nucleic acids has been recently shown to produce VLPs with strongly reduced 
polydispersity, showing therefore that the size dispersion is mainly determined by the nucleic 
acid content of VLPs[31]. 
  One other potential pitfall of the model is that HIV-1 self-assembly is a rich and 
complicated process for which it is not clear whether equilibrium considerations like the one 
underlying our model can apply. However, even within the framework of out-of-equilibrium 
self-assembly, the entropic arguments should still hold as the number of configurations of the 
system is drastically changed upon self-assembly. Despite these limitations, it is remarkable 
that such a simple model is able to qualitatively explain the role of viral RNA in HIV-1 
assembly at regulating the size distribution of viral particles. 
 
Material and methods  
 
Cell culture 
Human 293T cells used in this study were maintained in Dulbecco’s modified essential 
medium (DMEM) supplemented with 10% fetal calf serum (FCS) and antibiotics 
(penicillin/streptomycin). 
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DNA Plasmids 
The plasmid expressing HIV-1 Gag alone (pGag) and the plasmid expressing HIV-1 Gag, 
GagPol (lentiviral vector named pCMVΔ8.91) were respectively described in Burniston  et 
al.[32] and Zufferey  et al.[21].  Another plasmid is expressing a non infectious HIV-1   « ψ » 
mRNA, as described by Naldini et al[22]. An empty vector (pcDNA3.1 expressing the 
fluorescent protein Venus) is used as a control for "Mock" transfected cells. 
 
Antibodies 
Antibodies used in this study are a mouse anti-CAp24 and a rabbit anti-MAp17 [NIH, USA], 
the rabbit anti-IN was a gift of Dr JF.Mouscadet (LBPA, ENS Cachan), the rabbit anti-RT 
was a gift of Dr JL.Darlix (ENS Lyon). The anti-mouse and anti-rabbit antibodies coupled to 
horseradish peroxidase [Dako ] were used for immunoblot detection. 
 
Particles production and purification 
To obtain non-infectious HIV-1 VLPs, human HEK 293T cells were transfected with the 
plasmid p8.91 that encodes the polyproteins Gag and Gag-Pol, as well as for the regulatory 
viral proteins Tat and Rev. The resulting VLPs give rise to mature viral particles in which 
Gag is cleaved by the viral protease and the core is formed. Immature VLPs were produced 
by a plasmid encoding only Gag and thus yielding viral particles in which the Gag remains 
uncleaved. All samples were produced in the presence or in the absence of a plasmid 
expressing the HIV-1 ψRNA[22]. The "mock" condition is obtained by cell transfection with 
a "mock" plasmid that is not coding for viral Gag or any other viral proteins. 
The DNA plasmid-phosphate transfection complex was produced by mixing a phosphate 
buffer (HBS) with the corresponding plasmids previously supplemented with CaCl2 (250 
mM), and then added on plated cells. Cells were incubated at 37 °C overnight. Then, cells 
were washed with PBS and new medium was added for 24 hours of virus production. The 
medium containing viruses was collected and clarified by filtration (0,45 µm). Then, it was 
deposit at the top of a double layer sucrose gradient of 20% and 30% sucrose in PBS and 
submitted to an ultracentrifugation in a Beckman SW41 rotor at 27000 rpm for 2 hours at 
4°C. VLPs were isolated at the bottom. Viral cores were isolated by adding the detergent 
Triton X-100 (0.05%) to the upper sucrose layer. Viral particles or cores were diluted in TNE 
(10 mM Tris pH 7.4, 100 mM NaCl, 1 mM EDTA, pH 7.4), at 4°C for 2 hours and directly 
deposited on an AFM surface. This technique is adapted from Accola et al[33]. 
 
Immunoblotting 
To analyze viral proteins by immunoblot analysis, the proteins contained in the viral pellets 
(VLP or cores)  were separated onto an SDS–10% PAGE gel and transferred onto a 
polyvinylidene difluoride membrane (Hybond-P, Amersham), and immunoblotting was 
performed by using the corresponding antibodies, as described previously[34]. Secondary 
antibodies were revealed by using the SuperSignal West Pico substrate (Thermo Scientific). 
The signals were revealed by autoradiography on Fuji film. 
 
Reverse transcription assay 
Ten microliters of supernatant containing virus-like particles was added to 50 µl of a reverse 
transcription mix (60 mM Tris pH 8.0, 180 mM KCl, 6 mM MgCl2, 0.6 mM EGTA pH8.0, 
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0.12% Triton X-100, 6 mM dithiothreitol, 6 µg/mL oligo dT, 12 µg/ml poly rA, and 20 
µCi/ml [α-32P]dTTP [specific activity, 3,000 Ci/mmol]). After 1 h of incubation at 37°C, 5 µl 
was loaded onto DEAE paper (DE-81; Whatman) and then rinsed with 2× SSC (0.3 M NaCl, 
0.03 M sodium citrate [pH 5]). The radioactivity (X-rays) of the sample was recorded by a 
storage phosphorscreen (Molecular Dynamics), measured with a phosphorimager (Fuji), and 
quantified by using MultiGauge software (Fuji). 
 
Atomic Force Microscopy imaging 
An atomically flat mica (grade V-I, SPI) surface functionalized with positively charged poly-
L-lysine (Sigma Aldrich) was chosen to assure the attachment of viral particles for AFM 
imaging: 10 µl poly- L-lysine (0,01%) were deposited onto freshly cleaved mica-discs. After 
an incubation of 30 seconds, disks were rinsed twice with 1 ml of ultrapure water and dried by 
a nitrogen flow. A 5 µl-droplet of the viral agent obtained after purification was applied to the 
surface and incubated for two minutes (VLPs) or 15 minutes (viral cores) to assure a 
sufficient adsorption. 
Imaging was performed in Tapping Mode with a Nanoscope IIIa Multimode AFM operated 
with a JVH- scanner (Digital Instruments Veeco, Santa Barbara). Since our main objective in 
this work is to compare size distributions of VLPs under different production conditions, we 
chose to image dried samples, although this might flatten particles, in order to avoid 
desorption of particles during scanning of the surface by the AFM tip. For imaging in air, the 
sample was rinsed with 1 ml of ultrapure water and gently dried by a nitrogen flow. Imaging 
was executed with silicon tips (resonance frequency ~ 350 kHz, kcantilever = 40 N/m). 
According to the scan size of 0.5-3 µm, a scan rate between 1 and 3 Hz was chosen.  
Additional AFM imaging in liquid conditions are provided as supplemental data. 
  
Automated image analysis 
Images acquired by AFM were analyzed in an automated fashion using home-made 
MATLAB (from Mathworks) scripts. The principle of this analysis is summarized in the 
figure 2. The aim of developing such automated image analysis is to be able to select particles 
based on objective criteria. While using this approach, caution should be exercised in order to 
optimize the parameters of the filters, allowing to reject aberrant particles (broken particles, 
aggregates...) and select normal particles, while keeping size dispersion and good statistics.  
 The first step of the image analysis is to use standard flattening procedure of the raw AFM 
image in order to get rid of typical piezo-electric drift during image acquisition. The next step 
is to use a low height selection (12nm in our case) in order to focus on image parts above the 
roughness of the naked substrate (mica+Poly-L-Lysine coating) and to make a binary image 
out of it. Then selection is made on image parts that enter a certain area range. For VLPs, an 
optimal choice for this range is between 7000nm
2
 (equivalent to 94nm diameter) and 10
5
 nm
2 
(equivalent to 357nm diameter). Another height selection is used to ensure that the selected 
parts of the image reach a minimal height (here 25nm) compatible with the a priori size of the 
particle to be focused on. Then particles partly lying on one edge of the image are removed. 
Finally, the actual shape of the binary particles on the image is used to extract the perimeter Pi 
, the area Ai, the major axis Mi and the minor axis mi. This information is used in order to 
perform a last selection step with one morphological parameter: the fractal parameter 
. The fractal parameter allows to focusing on particles that have smoothed contour 
(0.75<Fi<1) or shaky contour (Fi<0.75). In particular, this parameter is easily optimized in 
order to reject multiple overlapping particles that went through the area selection step. For an 
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ideal disk, the value of fractal parameter is 1. The final binary image is then multiplied by the 
original image and is now ready for the computation of statistical properties of the particles. 
 
 
 
Model of self-assembly process 
The self-assembly of particles and the influence of the RNA content is modelized thanks to a 
classical description of micellization[18,19,24,27,35]. The aim of the model is to predict the 
partitioning of different molecules (identical proteins, identical large RNAs, and identical 
small RNAs) into the products of self-assembly under well defined conditions and at 
equilibrium. In particular, we will seek for which conditions it is possible to reproduce 
qualitatively the experimental results. For the sake of simplicity, we present a bimodal version 
of the calculation, for which there are only two possible products (labelled 1 and 2). We 
recently published an extended analysis of the present model including the effect of particle 
polydispersity[23]. It turns out that the results of the present simplified bimodal analysis do 
reproduce quantitatively the one of the more complex model. This justifies our use of 
simplified bimodal model, as a pedagogical route in order to interpret the experimental 
results. The numerical calculations presented in the main text are based on the resolution of 
the equilibrium equations associated to the self-assembly. More information on this model are 
available in the supplemental data.  
Assuming that initial concentrations of respectively proteins, large and small RNAs are noted  
φ
0
,φ
r+
,φ
r−  ,  the equations for the case of bimodal self-assembly are written as a combination 
of mass conservation laws and mass actions laws, as it is demonstrated in the supplemental 
data: 
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= c
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In these equations, c
0
,c
r+
,c
r−
 are respectively the concentration of proteins, large RNA and 
small RNA that remain in solution as monomeric species. The particles 1 and 2 have 
respectively p1 and p2 proteins, n1 and n2 large RNAs, and m1 and m2 small RNAs. The free 
energy of formation of particle 1 and 2 per protein are respectively g1 and g2 in units of 
thermal energy kBT. Finally the quantity v0 is a typical volume allowing to use dimensionless 
concentrations in the equations. An additional constraint is imposed on the relation between 
number of proteins and RNAs, as it is discussed in the supplementary material. The two 
relations are written as  
p
1
= K
v
n
1
+ K
c
m
1
p
2
= K
v
n
2
+ K
c
m
2
 
, where Kv  and Kc are respectively proportional to the length of viral and cellular RNAs. In 
order to show the general trends of the model, we used small numbers of proteins per 
aggregate for the sake of convenience. As a consequence, only relative concentrations are 
relevant to the discussion, and the absolute values of concentrations are not to be compared to 
real experimental situations. We checked that the results presented here are not strongly 
dependent on the precise values of parameters. The first parameters used to compute figure 5 
are the following: p
1
= 21,n
1
= 2,m
1
= 10,g
1
= −2 ; p
2
= 21,n
2
= 0,m
2
= 14,g
2
= −2 ; 
φ
0
= 0.4,v
0
= 2,K
v
= 3,K
c
= 1.5 . The second set of parameters used to compute figure 6 are 
the following: p
1
= 21,n
1
= 2,m
1
= 10,g
1
= −2 ; p
2
= 42,n
2
= 0,m
2
= 28,g
2
= −2 ; 
φ
0
= 0.4,v
0
= 2,K
v
= 3,K
c
= 1.5 .  
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Figure Captions 
 
Figure 1: Biochemical characterization of VLPs and viral cores, and AFM imaging. (a) 
Immunoblot of HIV-1 for mature and immature VLPs and cores. (b) Reverse transcription test 
on mature VLPs and cores in the presence or the absence of ψRNA in the VLPs or cores. (c) 
Typical images of mature VLPs. (d) Typical images of viral cores. 
 
Figure 2: Automated image analysis. (a) Example of the successive image analysis steps 
applied on a single image. (b) Cartoon of the principle of image analysis. (c) Various 
representation (color map, contour plots, 3D plots) of particles that were selected. Top VLP, 
down core. Interestingly, the contour map of the VLP shows a pronounced asymmetry close 
to its maximal height, reflecting the presence of an asymmetric object inside the VLP. 
 
Figure 3: Statistical analysis of size distributions of VLPs and cores obtained through 
automated image analysis. The number of particles is indicated by the value N. (a) and (c) 2D 
histograms of short and long diameters for respectively mature VLPs and cores. (b) Short 
diameter histogram obtained by projecting the 2D histograms for VLPs and cores. (d) and (f), 
long diameter histogram obtained projecting the 2D histograms for VLPs and cores. (e) 
Typical example of short and long diameters measured on a single particle. 
 
Figure 4: Influence of the presence or absence of viral ψRNA on particle morphogenesis. The 
number of particles is indicated by the value N. (a) and (c) 2D histogram of short and long 
diameters for respectively VLPs in the absence and in the presence of ψRNA. The size 
distribution is shifted toward smaller value, and its dispersion is reduced. (b) and (d) 2D 
histogram of short and long diameters for respectively cores in the absence and in the 
presence of ψRNA. The same shift in the distribution is observed, although with w weaker 
amplitude. (e) Box plot  of equivalent diameters summarizing the previous results. The 
equivalent diameter is obtained by converting the 2D projected area of the particle into the 
diameter of a disk that would give the same area. 
 
Figure 5: Model of entropic selection of viral genome at fixed particle size. (a) Cartoon of the 
self-assembly. The model is specialized to bimodal products of self-assembly, in which the 
size of particle are equal and the RNA content are different. (b) Typical large RNA titration 
computed thanks to the model detailed in the supplemental data. The value of parameters 
chosen for the calculation are found in the material and methods. Blue circles correspond to 
particles with large RNA, and green crosses correspond to particles lacking large RNA.(c) 
Phase diagram small RNA / large RNA. The boundary for which the concentration of both 
particles are equal is shown by blue filled circles. The line joining the circles is drawn to 
guide the eye. 
 
Figure 6: Combined model of viral genome and particle size entropic selection. The model is 
specialized to bimodal products of self-assembly, with different particle size and different 
RNA content. (a) Typical large RNA titration computed thanks to the model detailed in the 
supplemental data. The value of parameters chosen for the calculation are found in the 
material and methods. In this case, the number of proteins in the "large particles" is twice the 
number of proteins in the small one. Red circles correspond to small particles with large 
RNA, and pink crosses correspond to large particles lacking large RNA. (b) Phase diagram 
small RNA / large RNA. The boundary for which the concentration of both particles are equal 
is shown by red filled circles. The line joining the circles is drawn to guide the eye. For 
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comparison, the boundary at fixed particle sizes found in figure 5b is depicted by a blue 
dotted line.  






